Table 1 Summary of the clinical features of the patients
From: Point-of-care lung ultrasound imaging in pediatric COVID-19
Variables studied | Clinical classification | |||
|---|---|---|---|---|
Mild (n:18) | Moderate (n:8) | Severe/critical (n:8) | Total (n:34) | |
Epidemiological data | ||||
Age, months Median (range) | 23 (0.46–192) | 4 (1–132) | 29 (0.3–132.16) | 13 (0,3–192) |
Male sex n (%) | 14 (78) | 4 (50) | 3 (37) | 21 (62) |
Chronic medical condition n (%) | 9 (50) | 6 (75) | 3 (37) | 18 (53) |
Symptoms n (%) | ||||
Fever | 18 (100) | 7 (87) | 7 (87) | 32 (94) |
Rhinorrhea | 5 (27) | 4 (50) | 0 | 9 (26) |
Cough | 5 (27) | 5 (62) | 7 (87) | 17 (50) |
Dyspnea | 0 | 8 (100) | 7 (87) | 15 (44) |
Nausea/vomiting | 2 (11) | 0 | 2 (25) | 4 (12) |
Respiratory failure | 0 | 0 | 7 (87) | 7 (20) |
Shock | 0 | 0 | 5 (62) | 5 (15) |
Hypoxemia | 0 | 0 | 8 (100) | 8 (23) |
Early cardiac failurea | 0 | 0 | 2 (25) | 2 (6) |
Pulmonary edema | 0 | 0 | 1(12) | 1 (3) |
Laboratorial data | ||||
D-Dimer (ng/mL) Median (range) | 1251 (306–5809) | 1990 (190–4127) | 18,536 (1932–54,153) | 2250 (190–54,153) |
C-Reactive Protein (mg/L) Median (range) | 5.4 (0.3–130) | 3 (0.5–114) | 185.5 (0.3–447) | 20 (0.3–447) |
Intensive care support n (%) | ||||
Mechanical ventilation | 0 | 0 | 5 (62) | 5 (15) |
Vasoactive drug | 0 | 0 | 5 (62) | 5 (15) |
Imaging data n (%) | ||||
Chest RX performed | 12(66) | 6 (75) | 7 (87) | 25 (73) |
Chest RX abnormality | 0 | 1/6 (16) | 6/7(85) | 7/25 (28) |
Chest CT performed | 3 (16) | 3 (37) | 6 (75) | 12 (35) |
Chest CT abnormality | 1/3 (33) | 3/3 (100) | 6/6 (100) | 10/12 (83) |
Lung US scoreb Median (range) | 0 (0–15) | 4 (0–14) | 17 (2–30) | 2,5 (0–30) |